Stay updated on Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page
- Check3 days agoChange DetectedThere are no additions or deletions to summarize for this page based on the provided changes data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s UI release/revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check32 days agoChange DetectedMantua, Italy was added to the list of locations and Mantova, Italy was removed.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded the MeSH term 'Severe myoclonic epilepsy in infancy' to the Additional Relevant MeSH Terms on the study record.SummaryDifference0.1%

- Check46 days agoChange DetectedRemoved 'Dravet syndrome' from the list of conditions in the study details, affecting how the study's scope and eligibility are described.SummaryDifference0.0%

Stay in the know with updates to Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.